Anticancer activities of artemisinin and its bioactive derivatives (Q37626137)

21 August 2017

1 reference

title

Anticancer activities of artemisinin and its bioactive derivatives (English)

1 reference

21 August 2017

0 references

Gary L Firestone

1 reference

21 August 2017

Shyam N Sundar

series ordinal

1 reference

21 August 2017

publication date

30 October 2009

1 reference

Expert Reviews in Molecular Medicine

21 August 2017

published in

1 reference

21 August 2017

1 reference

21 August 2017

page(s)

e32

1 reference

Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Dihydroartemisinin potentiates the cytotoxic effect of temozolomide in rat C6 glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Artesunate derived from traditional Chinese medicine induces DNA damage and repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Apoptotic signaling pathways as a target for the treatment of liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Pharmacokinetics and pharmacodynamics of endoperoxide antimalarials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Molecular modes of action of artesunate in tumor cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Stress-activated MAP kinase cascades in cellular senescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Calcium and survivin are involved in the induction of apoptosis by dihydroartemisinin in human lung cancer SPC-A-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Understanding artemisinin-induced brainstem neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

The role of calcium, P38 MAPK in dihydroartemisinin-induced apoptosis of lung cancer PC-14 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

The p38 MAPK pathway mediates interleukin-1-induced Sertoli cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Sp1 interactions with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Dihydroartemisinin is an inhibitor of ovarian cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Master regulation of bile acid and xenobiotic metabolism via the FXR, PXR and CAR trio

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Androgen receptor in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Understanding the epidemiology, natural history, and key pathways involved in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Acquired resistance to oestrogen deprivation: role for growth factor signalling kinases/oestrogen receptor cross-talk revealed in new MCF-7X model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Inhibition of estrogen receptor alpha expression and function in MCF-7 cells by kaempferol

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

The influence of the route of administration of 17beta-estradiol, intravenous (pulsed) versus oral, upon DMBA-induced mammary tumour development in ovariectomised rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Tamoxifen induction of CCAAT enhancer-binding protein alpha is required for tamoxifen-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

ERbeta in breast cancer--onlooker, passive player, or active protector?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

New insights into the classical and non-classical actions of estrogen: evidence from estrogen receptor knock-out and knock-in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Androgen receptor knockout and knock-in mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Nuclear receptors: one big family

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Anti-inflammatory properties and regulatory mechanism of a novel derivative of artemisinin in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Dihydroartemisinin (DHA) induces caspase-3-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Inhibition of glutathione S-transferases by antimalarial drugs possible implications for circumventing anticancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Endocrine therapy for the treatment of postmenopausal women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Indole-3-carbinol inhibits Sp1-induced matrix metalloproteinase-2 expression to attenuate migration and invasion of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Artemisinin reduces human melanoma cell migration by down-regulating alpha V beta 3 integrin and reducing metalloproteinase 2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Costunolide, a sesquiterpene lactone from Saussurea lappa, inhibits the VEGFR KDR/Flk-1 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

The Antimalaria Agent Artemisinin Exerts Antiangiogenic Effects in Mouse Embryonic Stem Cell-Derived Embryoid Bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Chemokine receptors as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Induction of P-glycoprotein expression and function in human intestinal epithelial cells (T84).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Role of transferrin receptor and the ABC transporters ABCB6 and ABCB7 for resistance and differentiation of tumor cells towards artesunate

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Second generation, orally active, antimalarial, artemisinin-derived trioxane dimers with high stability, efficacy, and anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Hemoglobin catabolism and iron utilization by malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Artemisinin: mechanisms of action, resistance and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Drug combinations for malaria: time to ACT?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

7 January 2021

Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

7 January 2021

Declining estrogen receptor-beta expression defines malignant progression of human breast neoplasia.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

7 January 2021

The toxicity of artemisinin and related compounds on neuronal and glial cells in culture

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

7 January 2021

p38 and ERK MAP kinase mediates iron chelator-induced apoptosis and -suppressed differentiation of immortalized and malignant human oral keratinocytes

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

7 January 2021

Anti-angiogenic activity of torilin, a sesquiterpene compound isolated fromTorilis japonica

1 reference

https://api.crossref.org/works/10.1017%2FS1462399409001239

7 January 2021

10.1017/S1462399409001239

Identifiers

DOI

1 reference

21 August 2017

1 reference